A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome

Clinical trial NCT00287079 · COMPLETED

Trial details

NCT number: NCT00287079
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Clinically Isolated Syndrome

Start date: 2005-10-01
Primary completion: 2008-11-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.